-
- Ana Aparicio
- Authors' Affiliation: Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas
-
- Christopher J. Logothetis
- Authors' Affiliation: Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas
-
- Sankar N. Maity
- Authors' Affiliation: Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas
説明
<jats:title>Abstract</jats:title><jats:p>Small cell prostate carcinoma is a lethal variant of castration-resistant prostate cancer. Beltran and colleagues identified overexpression and amplification of both aurora kinase A (AURKA) and the MYCN proto-oncogene in the small cell prostate carcinomas and propose Aurora kinase A as a potential therapeutic target in this disease subset. Cancer Discovery; 1(6); 466–68. ©2011 AACR.</jats:p><jats:p>Commentary on Beltran et al., p. 487.</jats:p>
収録刊行物
-
- Cancer Discovery
-
Cancer Discovery 1 (6), 466-468, 2011-11-01
American Association for Cancer Research (AACR)
